60 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Metered Dose Inhaler

Known as: tiotropium bromide 2.5 MCG / olodaterol 2.5 MCG per INHAL Metered Dose Inhaler, 60 ACTUAT, OLODATEROL 2.5MCG/TIOTROPIUM 2.5MCG/ACTUAT INHL,ORAL,60D,4GM [VA Product], OLODATEROL/TIOTROP 2.5MCG/ACTUAT 60D INH 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2016
02420112016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND Two replicate, double-blind, placebo-controlled, 6-week crossover studies assessed the effect of the once-daily long… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
PURPOSE The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed increased effectiveness… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Review
2016
Review
2016
Chronic Obstructive Pulmonary Disease (COPD) is a chronic airway disease that can be prevented and treated. The recommendations… (More)
Is this relevant?
Review
2016
Review
2016
Tiotropium-olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-acting… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2015
2015
The novel long-acting β2-agonist olodaterol demonstrated an acceptable safety profile in short-term phase II clinical studies… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2014
2014
Zur Dauertherapie bei COPD kann seit Mai der langwirksame Beta2-Agonist (LABA) Olodaterol (Striverdi®) verordnet werden. Der… (More)
Is this relevant?
2014
2014
Zur Dauertherapie bei COPD kann seit Mai der langwirksame Beta2-Agonist (LABA) Olodaterol (Striverdi®) verordnet werden. Der… (More)
Is this relevant?
2014
2014
Zur Dauertherapie bei COPD kann seit Mai der langwirksame Beta2-Agonist (LABA) Olodaterol (Striverdi®) verordnet werden. Der… (More)
Is this relevant?
2014
2011
2011
BACKGROUND Current guidelines recommend long-acting bronchodilators as maintenance therapy in COPD when symptoms are not… (More)
Is this relevant?